Dr. Bernstein, you stated that the idea of a mixed vaccine regimen, that is, a first dose of an mRNA vaccine followed by a second dose of an adenovirus vaccine, was scientifically sound and worth further study.
What do you think are the advantages, disadvantages and risks of such a combination? Do we have any evidence on this—